Stay updated on Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial
Sign up to get notified when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.

Latest updates to the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page
- Check3 days agoChange DetectedHeader now shows Revision: v3.5.4, replacing v3.5.3. This indicates a backend interface update with no changes to study details or user interactions.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s footer revision has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; no visible changes to the study details on the page.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No visible changes to page content or layout.SummaryDifference0.0%

Stay in the know with updates to Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.